Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyPsoriasisTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyPsoriasisTeam Member asked a question 💭
Dallas, TX

GoodRx (GDRX) announced a new partnership with Boehringer Ingelheim to provide discounts for a biosimilar to rheumatoid arthritis drug Humira Thursday, adding to an increasingly competitive market.

The move gives Boehringer more visibility for Cyltezo in what is now a crowded biosimilar market, with 10 products with similar formulations — biologically similar — competing against AbbVie's (ABBV) blockbuster Humira. I heard they will do a zero copay for Cyltezo😁

July 18, 2024
 · 
Reactions

Related Questions

View All
A MyPsoriasisTeam Member asked a question 💭
Waterbury, CT

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In